VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.

Saved in:
Bibliographic Details
Title: VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.
Authors: Fogarty H; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.; Department of Haematology, Children's Health Ireland at Crumlin, Dublin, Ireland.; National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland., Ahmad A; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Atiq F; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Doherty D; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Ward S; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Karampini E; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Rehill A; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Leon G; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Byrne C; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland., Geoghegan R; Department of Haematology, Children's Health Ireland at Crumlin, Dublin, Ireland., Conroy H; Department of Haematology, Children's Health Ireland at Crumlin, Dublin, Ireland., Byrne M; National Coagulation Centre, St. James's Hospital, Dublin, Ireland., Budde U; Department of Haemostaseology, MVZ Medilys Laborgesellschaft mbH, Hamburg, Germany., Schneppenheim S; Department of Haemostaseology, MVZ Medilys Laborgesellschaft mbH, Hamburg, Germany., Sheehan C; Department of Haematology, St. James's Hospital, Dublin, Ireland., Ngwenya N; Department of Haematology, St. James's Hospital, Dublin, Ireland., Baker RI; Western Australia Centre for Thrombosis and Haemostasis, Perth Blood Institute, Murdoch University, Perth, WA, Australia.; Irish-Australian Blood Collaborative Network, Dublin, Ireland and Perth, Australia., Preston RJS; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.; National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland., Tuohy E; Department of Haematology, St. James's Hospital, Dublin, Ireland., McMahon C; Department of Haematology, Children's Health Ireland at Crumlin, Dublin, Ireland.; National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland., O'Donnell JS; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.; National Children's Research Centre, Children's Health Ireland at Crumlin, Dublin, Ireland.; National Coagulation Centre, St. James's Hospital, Dublin, Ireland.; Irish-Australian Blood Collaborative Network, Dublin, Ireland and Perth, Australia.
Source: Blood advances [Blood Adv] 2023 Nov 28; Vol. 7 (22), pp. 6974-6989.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2023010824